DEVELOPING
LIVING TISSUE

Highly customized and physiologically relevant 3D human tissues.

We are strategically partnering with world-class life science companies, as well as academic researchers, to develop a portfolio of 3D bioprinted human tissues. These tissues are advancing drug development by providing predictive pre-clinical models and enabling regenerative medicine through the development of implantable tissue therapies.

LEARN MORE
3D bioprinted human tissues

CREATING
MEANINGFUL
IMPACT

The Future is Here

OUR
TECHNOLOGY

Lab-on-a-Printer™
3D Bioprinting

Our 3D bioprinting technology integrates 3D printing, microfluidics, and computer-aided design for advanced tissue engineering

Our 3D bioprinting platform enables the rapid creation of 3D heterogeneous, structurally accurate, and functional tissues. Our technology uses a multifunctional microfluidic printhead capable of programmatically manipulating and sequencing multiple biomaterials, living cells, extracellular matrix content, growth factors, bioactive compounds and other bioinks ‘on the fly’ during tissue printing.

SEE MORE
Lab-on-a-Printer 3D Bioprinting

Next-Generation
3D Bioprinting

The RX1 3D Bioprinting
Platform

The world’s first 3D bioprinting technology able to capture the level of detail required to recapitulate human tissue.

The RX1 3D Bioprinter merges critical advancements in 3D printing and microfluidics to accurately capture the detail required to recreate complex human tissues.

SEE PRODUCT
RX1 3D Bioprinting Platform
See more about Aspect Biosystems

THE LATEST

LATEST NEWS

Aspect Biosystems on CNBCAspect Biosystems on BloombergAspect Biosystems on The EconomistAspect Biosystems on The Wall Street JournalAspect Biosystems on Canadian Business
MORE NEWS